According to our data, miR-183-5p targets FOXO1, SMAD4, and GSK3B genes involved in transcriptional misregulation in cancer, FOXO signaling pathway and alcoholic liver disease. This evidence concerns the gene SMAD4 and alcoholic liver diseases.